Grifols SA - ADR is a global pharmaceutical and chemical manufacturer specialising in development of plasma-derived medicines and other biopharmaceutical solutions. It offers comprehensive services to patients in numerous countries.
As a part of the healthcare industry, Grifols SA aims to provide life-enhancing benefits by producing plasma-derived protein therapies. The company operates through four business divisions: BioScience, Diagnostic, Hospital, and Bio Supplies. Its portfolio of products includes biotechnology research, biological materials and manufacturing of pharmaceutical products.
Keep an eye on the price movements of GRFS stock by adding it to your eToro watchlist.